Pages that link to "Q42673590"
Jump to navigation
Jump to search
The following pages link to An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables (Q42673590):
Displaying 24 items.
- Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus (Q24194970) (← links)
- Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus (Q24200450) (← links)
- Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus (Q24240051) (← links)
- 20 µg versus >20 µg estrogen combined oral contraceptives for contraception (Q24240908) (← links)
- 20 µg versus >20 µg estrogen combined oral contraceptives for contraception (Q24243992) (← links)
- Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus (Q24245244) (← links)
- Metabolic effects of contraceptive steroids (Q28236638) (← links)
- Effect of hormonal contraceptives on lipid profile and the risk indices for cardiovascular disease in a Ghanaian community (Q33734372) (← links)
- Ethynilestradiol 20 mcg plus Levonorgestrel 100 mcg: Clinical Pharmacology (Q34588375) (← links)
- Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism (Q35599726) (← links)
- Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives (Q36425257) (← links)
- Contraceptive hormone use and cardiovascular disease (Q37138852) (← links)
- Choosing the best contraceptive method for the adult with congenital heart disease (Q37535054) (← links)
- Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review (Q38501601) (← links)
- Metabolic impact of combined hormonal contraceptives containing estradiol (Q38836319) (← links)
- Cardiovascular risk in Egyptian healthy consumers of different types of combined oral contraceptives pills: A comparative study (Q38987743) (← links)
- Serum lipid and lipoprotein changes induced by preparations containing low-dose ethinylestradiol plus levonorgestrel (Q44720243) (← links)
- Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study (Q47206352) (← links)
- Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis (Q48119725) (← links)
- Ovarian Lipid Metabolism Modulates Circulating Lipids in Premenopausal Women (Q50449755) (← links)
- Pharmacoepidemiology and drug safety (Q78601142) (← links)
- Metabolic profile of a continuous versus a cyclic low-dose combined oral contraceptive after one year of use (Q83644767) (← links)
- Blood Pressure Effects of the Oral Contraceptive and Postmenopausal Hormone Therapies (Q84085500) (← links)
- Effectiveness and safety assessment of drospirenone/ethinyl estradiol tablet in treatment of PCOS patients: a single center, prospective, observational study (Q89924233) (← links)